Crossmark

Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05026-w

Published Online: 2021-01-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marquis-Gravel, Guillaume https://orcid.org/0000-0003-2965-1504
Robertson, Holly

Jones, W. Schuyler

Riley, Danielle

Ford, Daniel E.

Crenshaw, David

Joosten, Yvonne A.

Rudov, Lindsey

Hernandez, Adrian F.

Hess, Rachel
Funding

Funding for this research was provided by:

Patient-Centered Outcomes Research Institute (ASP-1502-27029)
License Information

Text and Data Mining valid from 2021-01-25

Version of Record valid from 2021-01-25
More Information

Article History

Received: 18 February 2020

Accepted: 6 January 2021

First Online: 25 January 2021

Ethics approval and consent to participate

: The study was approved by the local IRB of every study site.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below